Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 1, 2000Clinical Infectious Diseases

Mechanisms of Action and Resistance of Older and Newer Fluoroquinolones

View Full Paper
Ask AI
Bookmark
Share

Authors

DHDavid C. HooperTufts University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

David C. Hooper (2000) studied this question.

synapsesocial.com/papers/6a7075ac2fdcb5703edb5f05https://doi.org/10.1086/314056
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Detection of OXA-4 beta-lactamase in Pseudomonas aeruginosa isolates by genetic methods1999 · 107 citations
  2. 2Nucleotide sequence and characterization of the Staphylococcus aureus norA gene, which confers resistance to quinolones1990 · 483 citations
  3. 3Relationship between mutations in the coding and promoter regions of the norA genes in 42 unrelated clinical isolates of Staphylococcus aureus and the MICs of norfloxacin for these strains1998 · 31 citations
  4. 4Hydrophilicity of quinolones is not an exclusive factor for decreased activity in efflux-mediated resistant mutants of Staphylococcus aureus1996 · 83 citations
  5. 5Efflux-mediated fluoroquinolone resistance in Staphylococcus aureus1993 · 413 citations